Virginia Commonwealth University, via the Wright Center for Clinical and Translational Research, has joined a network of other Clinical and Translational Science Award (CTSA) hubs that will help VCU researchers navigate the complex regulatory world of drug and device development.
VCU is the first institution outside the Carolinas to join the Regulatory Guidance for Academic Research of Drugs and Devices (ReGARDD) network.
With ReGARDD, a VCU researcher has a larger regulatory pool to draw from in meeting their research needs. The network has resources, training, events, templates and guidance on navigating drug and device development in the academic setting. Researchers can register to receive upcoming educational events and updates in their inboxes on their website.
ReGARDD is led by regulatory affairs specialists and experts from North and South Carolina institutions that receive funding from the National Institutes of Health’s CTSA Program. The other institutions are the University of North Carolina at Chapel Hill, Duke University, Wake Forest School of Medicine, and RTI International and the Medical University of South Carolina.
VCU staff with regulatory expertise will pool resources with the other institutions. The network enables the sharing of ideas, lessons learned and historical information, as well as the development of successful strategies to assist the academic researcher in navigating an increasingly complex regulatory environment.
Find more information about VCU’s FDA regulatory program at the Office of the Vice President for Research and Innovation.